BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28975193)

  • 1. Accuracy of a Staging System for Prognosis of 5-Year Survival of Patients With Nasopharyngeal Carcinoma Who Underwent Chemoradiotherapy.
    Huang CI; Chen LF; Chang SL; Wu HC; Ting WC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1086-1091. PubMed ID: 28975193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
    Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
    Loong HH; Ma BB; Leung SF; Mo F; Hui EP; Kam MK; Chan SL; Yu BK; Chan AT
    Radiother Oncol; 2012 Sep; 104(3):300-4. PubMed ID: 22300609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
    Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
    PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
    Kitpanit S; Jittapiromsak N; Sriyook A; Prayongrat A; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Jpn J Clin Oncol; 2019 Dec; 49(12):1100-1113. PubMed ID: 31334768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?
    Yoon HM; Ryu KW; Nam BH; Cho SJ; Park SR; Lee JY; Lee JH; Kook MC; Choi IJ; Kim YW
    J Am Coll Surg; 2012 Jan; 214(1):88-96. PubMed ID: 22036661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Wu JS; Tsai YC; Jian JJ; Chen HH; Horng CF; Cheng SH
    Head Neck; 2018 Sep; 40(9):2070-2077. PubMed ID: 29756398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumor volume of nasopharyngeal carcinoma: significance for survival.
    Lee CC; Ho HC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Chou P
    Auris Nasus Larynx; 2008 Sep; 35(3):376-80. PubMed ID: 18249078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
    Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
    Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
    Lu J; Dai Y; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
    BMC Cancer; 2019 Mar; 19(1):216. PubMed ID: 30857518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
    Hu QY; Liu P; Wang L; Fu ZF
    Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma.
    Chua DT; Sham JS; Wei WI; Ho WK; Au GK
    Cancer; 2001 Dec; 92(11):2845-55. PubMed ID: 11753958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.
    Xu C; Chen YP; Liu X; Li WF; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Tang LL; Lin AH; Sun Y; Ma J
    Oral Oncol; 2017 Jun; 69():99-107. PubMed ID: 28559028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Volume Predicts Survival Rate of Advanced Nasopharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy.
    Qin L; Wu F; Lu H; Wei B; Li G; Wang R
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):598-605. PubMed ID: 27071443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.
    Chen Y; Zhang G; Zhao B; Huang C; Ling Y; Li Y; Zhou Z
    Surg Oncol; 2019 Jun; 29():90-96. PubMed ID: 31196500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.